Mirum Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Mirum Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2019 to Q2 2024.
  • Mirum Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $8.76M, a 443% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $8.76M +$7.15M +443% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $680K -$607K -47.2% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.28M -$147K -10.3% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $1.43M +$174K +13.9% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $1.61M +$1.31M +438% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $1.29M -$181K -12.3% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $1.43M -$138K -8.8% Dec 31, 2022 10-K 2024-03-15
Q3 2022 $1.25M -$410K -24.6% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $300K -$1.46M -82.9% Jun 30, 2022 10-K 2023-03-08
Q1 2022 $1.47M -$386K -20.8% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $1.57M -$380K -19.5% Dec 31, 2021 10-K 2023-03-08
Q3 2021 $1.66M -$365K -18% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $1.76M -$349K -16.6% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $1.85M -$426K -18.7% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $1.95M -$412K -17.5% Dec 31, 2020 10-K 2022-03-09
Q3 2020 $2.03M +$1.09M +116% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $2.11M +$1.14M +117% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $2.28M Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $2.36M Dec 31, 2019 10-K 2021-03-09
Q3 2019 $941K Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $969K Jun 30, 2019 10-Q 2019-08-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.